NP 7557

Drug Profile

NP 7557

Latest Information Update: 25 May 2006

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Nastech Pharmaceutical Company
  • Class
  • Mechanism of Action Acetylcholinesterase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Alzheimer's disease

Most Recent Events

  • 25 May 2006 No development reported - Preclinical for Alzheimer's disease in USA (Intranasal)
  • 24 Jul 2002 Preclinical trials in Alzheimer's disease in USA (Intranasal)
  • 24 Jul 2002 A preclinical study has been added to the Alzheimer's Disease and Cognition Disorders pharmacodynamics section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top